Home›Conditions›Xanthelasma (Eyelid Deposits)

Lesion Assessment · Lipid Review · CityLink Mall

Xanthelasma Singapore —
A Cosmetic Sign

Atelier Aesthetics · Medical Director: Dr. Sin Yong · Updated 6 Oct 2026

The yellow plaques at the inner eyelid are cholesterol held inside cells in the skin. They are harmless in themselves, they are frequently the first visible indication of a lipid abnormality, and they recur after removal more often than most people are told.

Book a Consultation DEKA Laser

The Mechanism

Cholesterol Held In Skin

Book a Consultation

Xanthelasma is not a growth, a wart or a blocked gland. It is a deposit — lipid taken up by macrophages in the superficial dermis, which become engorged and are then described as foam cells. Enough of them collected in one place produces the characteristic soft, flat, yellowish plaque, which is why the lesion is compressible rather than firm and why it has no defined capsule that could simply be lifted out.

The eyelid is the preferred site for reasons of local anatomy. The skin there is the thinnest on the body, there is very little subcutaneous fat, and the dermal vasculature and lymphatics are arranged in a way that appears to favour lipid retention. The medial canthal region of the upper lid is the most frequent location and the lesions are usually bilateral and roughly symmetrical — one plaque on one side alone is worth a second look rather than an assumption.

They enlarge slowly and coalesce. A lesion that begins as a small pale streak along the lid crease can extend over months to years into a broader plaque, and once established it does not regress on its own. Nothing about it threatens vision or lid function; the complaint is entirely appearance, and there is no clinical obligation to remove it.

What does carry clinical weight is what the deposit may indicate. A significant proportion of people with xanthelasma have an underlying lipid disorder, including familial hypercholesterolaemia, and the lesion can precede any other sign by years. Equally, a substantial number have entirely normal lipids, so the finding is a prompt to test rather than a diagnosis in itself. Either way the sensible response is a fasting lipid panel and a cardiovascular risk assessment with your family doctor — that is the part of this condition that actually matters.

Finding One
Foam Cells
Macrophages loaded with cholesterol esters sitting in the superficial dermis. There is no capsule and no defined edge, which is why removal is a matter of clearing an infiltrated layer rather than excising a discrete lump.
Finding Two
Site And Symmetry
Most commonly at the medial canthus of the upper lid, usually bilateral and broadly symmetrical. Thin eyelid skin with minimal subcutaneous support is the local reason this region is affected so consistently.
Finding Three
Lipid Association
A meaningful share of patients have an underlying dyslipidaemia, sometimes familial and sometimes otherwise silent. A fasting lipid panel is appropriate whether or not the lesions are removed, and the result may change more than the eyelid.
Finding Four
Recurrence
Xanthelasma returns after removal in a meaningful proportion of cases, often at the same site and often within a few years. It is more likely with extensive lesions and with uncontrolled lipids, and it should be part of the conversation beforehand.

Types

Four Bumps, Different Origins

Several small eyelid lesions look alike at conversational distance and are routinely confused, including by the people who have them. They arise from different structures, they are removed differently, and treating one as another is the usual reason an attempt at removal leaves a mark without clearing the lesion. The distinction is made on colour, consistency and distribution under magnification.

Xanthelasma is a cosmetic lesion with a medical message. Removing it without checking the lipids treats the sign and ignores what it may be signalling.

Dr. Sin Yong · Medical Director, Atelier Aesthetics

Specifications

Region
Eyelid skin, most often the medial upper lid — thinnest skin on the body
Assessment
Lesion mapped and photographed; differential from milia, syringoma and sebaceous hyperplasia; fasting lipid panel advised
Modalities
Ablative laser, surgical excision or chemical cauterisation — chosen by size, depth and lid laxity
Review
Healing reviewed at two weeks; lesions monitored for recurrence thereafter
Type I
Xanthelasma
Soft, flat to slightly raised, distinctly yellow, with an ill-defined border, typically at the medial upper lid and typically bilateral. It is a dermal lipid deposit, not a cyst, and it cannot be expressed or extracted — which is precisely why attempts to squeeze it do nothing except bruise thin skin.
Type II
Milia
Small, firm, white to cream, domed and sharply defined — keratin retained within a tiny cyst rather than lipid within macrophages. They sit anywhere on the lid and cheek and are removed by a completely different technique. Milia are frequently mistaken for early xanthelasma and are far simpler to deal with.
Type III
Syringoma
Skin-coloured or faintly yellow, firm, multiple and clustered, usually on the lower lids and often appearing from adolescence onward. These are benign proliferations of eccrine sweat ducts extending into the dermis. They are not lipid, they are not associated with cholesterol, and they are notoriously prone to returning after any treatment.

The Decision

Two Honest Points First

Two things should be said before any removal is planned, and they are the reason this page exists in the form it does. The first is that xanthelasma may be a marker of dyslipidaemia, and the appropriate response is a fasting lipid panel and a cardiovascular risk review with your family doctor or a physician. That applies whether or not you decide to have the lesions removed, and it applies particularly where the lesions are extensive, appeared young, or run in the family. Treating the eyelid and never checking the blood is the wrong order of priorities.

The second is that recurrence is common. These lesions return in a meaningful proportion of patients after any method of removal, more frequently where the plaques were large or multiple and where lipid abnormality remains uncontrolled. That does not make removal unreasonable — many people are content with an interval of several clear years — but it makes a single-session cure an unrealistic expectation, and anyone presenting it as one is misdescribing the condition.

Where removal is appropriate, eyelid skin governs the technique. It is the thinnest skin on the body, and it sits over a structure whose position and function are unforgiving of scar contracture; excessive depth risks hypopigmentation, visible scarring or, at worst, distortion of the lid margin. Extent, depth, skin laxity and phototype determine whether an ablative laser approach, careful surgical excision or a chemical method is the sensible choice, and in Asian skin the risk of post-inflammatory pigment change is a genuine part of that calculation rather than a footnote.

The DEKA laser platforms used at the practice

FAQ

Xanthelasma — Common Questions

Ask a Question
It means it should be checked. A substantial proportion of people with xanthelasma have an underlying lipid disorder — sometimes familial hypercholesterolaemia, which can be otherwise silent — and the lesion may appear years before anything else does. A significant number, however, have entirely normal lipids. The finding is a prompt for a fasting lipid panel and a cardiovascular risk assessment, not a diagnosis by itself, and that assessment belongs with your family doctor or physician rather than with a clinic treating the eyelid.
No. Xanthelasma does not regress spontaneously, and it generally enlarges slowly and coalesces over months to years. Correcting an underlying lipid abnormality is worth doing on its own merits and may slow progression, but it does not reliably clear plaques that are already established. What is already deposited in the dermis stays there unless it is removed.
No. The plaques are benign, they do not affect vision, they do not involve the eye itself, and they do not interfere with lid function except in unusually extensive cases. The reason to treat them is appearance. The reason to take them seriously is what they may indicate about lipids and cardiovascular risk, which is a separate matter handled by a physician.
They cannot be extracted, because there is nothing enclosed to extract. Unlike milia, which are keratin held within a tiny cyst wall, xanthelasma is lipid dispersed inside cells throughout the superficial dermis with no capsule and no defined edge. Pressure on thin eyelid skin achieves nothing except bruising and, if repeated, the inflammation that leads to pigment change in Asian skin.
Common enough that it should be planned for. Recurrence rates vary with the extent of the original lesions, the method used and whether lipid abnormality is controlled, and it most often reappears at or near the original site. Multiple or extensive plaques recur more readily than small isolated ones. This is not a reason to avoid removal — a clear interval of years is a reasonable outcome to want — but it is a reason to be told the truth about it beforehand rather than afterwards.
The risks follow from the anatomy. Eyelid skin is the thinnest on the body, so anything applied too deeply risks a visible scar, persistent redness or loss of pigment, and scar contracture in this location can in principle distort the lid margin. In deeper phototypes, post-inflammatory hyperpigmentation is a realistic outcome and needs to be anticipated rather than discovered. These are the reasons the technique is chosen conservatively and, where lesions are extensive, staged rather than attempted in one sitting.

Continue

Related at Atelier

Related
Milia Removal
The commonest lesion confused with xanthelasma — different structure, different technique, far simpler to clear.
Related
Mole Removal
How lesions on the face are assessed and removed, and where a lesion needs a diagnosis before anything else.
Related
Eye Bag Treatment
Periorbital assessment more broadly — several separate findings around the eye are routinely treated as one.

References

  1. Ministry of Health, Singapore
  2. HealthHub, Singapore — public health information

Atelier Aesthetics · Owned by AYA

Assessed first —
then treated.

1 Raffles Link, #B1-28, CityLink Mall, Singapore 039393 · +65 8023 7170

Book a Consultation